Results for tag: "PF ILD Drug"

The PF ILD Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat interstitial lung diseases (ILDs), a group of disorders that cause scarring of the lungs. These drugs are used to reduce inflammation, improve breathing, and slow the progression of the disease. Commonly prescribed drugs include corticosteroids, immunosuppressants, and biologics. The PF ILD Drug market is highly competitive, with many companies offering similar products. Major players include AbbVie, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Other companies, such as Amgen, Biogen, and Vertex, are also active in the market. Show Less Read more